Tuesday, October 22, 2019
AngioDynamics Announces Departure of CFO and Appointment of Interim CFO
LATHAM, N.Y. --(BUSINESS WIRE)--Oct. 22, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner , Executive Vice President and Chief...

  Thursday, October 3, 2019
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
  Fiscal 2020 First Quarter Highlights         Net sales of $66.0 million , an increase of 3.3% year over year       Gross margin increased 170 basis points year over year to 57.9%       GAAP loss per share of $0.03 ; adjusted earnings per share of $0.08         LATHAM, N.Y. --(BUSINESS WIRE)--Oct....

  Thursday, October 3, 2019
AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology
  LATHAM, N.Y. --(BUSINESS WIRE)--Oct. 3, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has acquired Eximo Medical, Ltd....

  Monday, September 9, 2019
AngioDynamics Awarded Premier’s Nationally Outsourced Implantable Infusion Port Agreement
LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 9, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that the Company has been awarded a dual-source group purchasing...

  Thursday, September 5, 2019
AngioDynamics to Report Fiscal 2020 First Quarter Financial Results on October 3, 2019
LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 5, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of...

  Wednesday, July 31, 2019
AngioDynamics Announces Appointment of Former Johnson & Johnson Executive Karen Licitra to its Board of Directors
LATHAM, N.Y. --(BUSINESS WIRE)--Jul. 31, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the appointment of Karen Licitra to its board of directors as a...

  Tuesday, July 23, 2019
AngioDynamics to Present at the Canaccord Genuity Growth Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jul. 23, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, will...

  Wednesday, July 10, 2019
AngioDynamics Reports Fiscal 2019 Fourth Quarter and Full-Year Financial Results
Fiscal 2019 Fourth Quarter Highlights Net sales of $96.3 million , an increase of 9.0% year over year and 5.2% organically Gross margin of 53.6%, flat year-over-year GAAP EPS of $1.54 per share; adjusted EPS of $0.25 per share Completed sale of NAMIC Fluid Management business to Medline Industries...

  Thursday, June 20, 2019
AngioDynamics to Report Fiscal 2019 Fourth Quarter and Full-Year Financial Results on July 10, 2019
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 20, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the fourth quarter and...

  Tuesday, June 4, 2019
AngioDynamics to Present at the Raymond James Life Sciences and MedTech Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 4, 2019-- AngioDynamics, Inc.  (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, will...

  Monday, June 3, 2019
AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc.
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 3, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it closed the previously announced sale of its NAMIC ® fluid...

  Tuesday, May 28, 2019
AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange
LATHAM, N.Y. --(BUSINESS WIRE)--May 28, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that representatives of the Company will ring the NASDAQ Stock...

  Wednesday, May 22, 2019
AngioDynamics Receives FDA Approval to Initiate Pilot Study for the Use of NanoKnife® to Treat Prostate Cancer
LATHAM, N.Y. --(BUSINESS WIRE)--May 22, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that the United States Food and Drug Administration ( FDA )...

  Monday, May 13, 2019
AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
LATHAM, N.Y. --(BUSINESS WIRE)--May 13, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced enrollment of the first patient in its NanoKnife ® Irreversible...

  Wednesday, April 17, 2019
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million
AngioDynamics to host conference call today at 5:00 p.m. ET LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 17, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, today announced that...